UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
	OMB Number:  3235-0582
	Expires:  July 31, 2024
	Estimated average burden
	hours per response........4

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number  811-06565

Tekla Healthcare Opportunites Fund

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla Healthcare Opportunities Fund

100 Federal Street, 19^th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code:  617-772-8500

Date of fiscal year end:  September 30

Date of reporting period:  7/1/22-6/30/23

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

Item 1. Proxy Voting Record.

Vote Summary

1LIFE HEALTHCARE, INC.

Security	68269G107	Meeting Type	Special
Ticker Symbol	ONEM	Meeting Date	22-Sep-2022
Record Date	22-Aug-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To adopt the Agreement and Plan of Merger, dated July 20, 2022 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among 1Life Healthcare, Inc. ("1Life"), a Delaware corporation, Amazon.com, Inc. ("Amazon"), a Delaware corporation, and Negroni Merger Sub, Inc. ("Merger Sub"), a Delaware corporation. Upon the terms and subject to the conditions of the Merger Agreement, Amazon will acquire 1Life via a merger of Merger Sub with and into 1Life, with 1Life continuing as the surviving corporation.	Management	For	For
2.	To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to 1Life's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.	Management	For	For
3.	To adjourn the special meeting of the 1Life stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.	Management	For	For

ABBOTT LABORATORIES

Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	28-Apr-2023
Record Date	01-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: R. J. Alpern	Management	For	For
1b.	Election of Director: C. Babineaux-Fontenot	Management	For	For
1c.	Election of Director: S. E. Blount	Management	For	For
1d.	Election of Director: R. B. Ford	Management	For	For
1e.	Election of Director: P. Gonzalez	Management	For	For
1f.	Election of Director: M. A. Kumbier	Management	For	For
1g.	Election of Director: D. W. McDew	Management	For	For
1h.	Election of Director: N. McKinstry	Management	For	For
1i.	Election of Director: M. G. O'Grady	Management	For	For
1j.	Election of Director: M. F. Roman	Management	For	For
1k.	Election of Director: D. J. Starks	Management	For	For
1l.	Election of Director: J. G. Stratton	Management	For	For
2.	Ratification of Ernst & Young LLP As Auditors	Management	For	For
3.	Say on Pay - An Advisory Vote on the Approval of Executive Compensation	Management	For	For
4.	Say When on Pay - An Advisory Vote on the Approval of the Frequency of Shareholder Votes on Executive Compensation	Management	1 Year	For
5.	Shareholder Proposal - Special Shareholder Meeting Threshold	Shareholder	Against	For
6.	Shareholder Proposal - Independent Board Chairman	Shareholder	Against	For
7.	Shareholder Proposal - Lobbying Disclosure	Shareholder	Against	For
8.	Shareholder Proposal - Incentive Compensation	Shareholder	Against	For

ABBVIE INC.

Security	00287Y109	Meeting Type	Annual
Ticker Symbol	ABBV	Meeting Date	05-May-2023
Record Date	06-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Class II Director: Robert J. Alpern	Management	For	For
1b.	Election of Class II Director: Melody B. Meyer	Management	For	For
1c.	Election of Class II Director: Frederick H. Waddell	Management	For	For
2.	Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2023.	Management	For	For
3.	Say on Pay - An advisory vote on the approval of executive compensation.	Management	For	For
4.	Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting.	Management	For	For
5.	Stockholder Proposal - to Implement Simple Majority Vote.	Shareholder	Against	For
6.	Stockholder Proposal - to Issue an Annual Report on Political Spending.	Shareholder	Against	For
7.	Stockholder Proposal - to Issue an Annual Report on Lobbying.	Shareholder	Against	For
8.	Stockholder Proposal - to Issue a Report on Patent Process.	Shareholder	Against	For

ACADIA HEALTHCARE COMPANY, INC.

Security	00404A109	Meeting Type	Annual
Ticker Symbol	ACHC	Meeting Date	18-May-2023
Record Date	23-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Michael J. Fucci	Management	For	For
1b.	Election of Director: Wade D. Miquelon	Management	For	For
2.	Approve an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan as presented in the Proxy Statement.	Management	For	For
3.	Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.	Management	For	For
4.	Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

AGILENT TECHNOLOGIES, INC.

Security	00846U101	Meeting Type	Annual
Ticker Symbol	A	Meeting Date	15-Mar-2023
Record Date	24-Jan-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director for a three-year term: Heidi K. Kunz	Management	For	For
1.2	Election of Director for a three-year term: Susan H. Rataj	Management	For	For
1.3	Election of Director for a three-year term: George A. Scangos, Ph.D.	Management	For	For
1.4	Election of Director for a three-year term: Dow R. Wilson	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation of our named executive officers.	Management	For	For
3.	To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.	Management	For	For
4.	To approve amendments to the Certificate of Incorporation to create a new stockholder right to call a special meeting.	Management	For	For
5.	An advisory vote on the frequency of the stockholder vote to approve the compensation of our named executive officers.	Management	1 Year	For

ALIGN TECHNOLOGY, INC.

Security	016255101	Meeting Type	Annual
Ticker Symbol	ALGN	Meeting Date	17-May-2023
Record Date	23-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Kevin J. Dallas	Management	For	For
1.2	Election of Director: Joseph M. Hogan	Management	For	For
1.3	Election of Director: Joseph Lacob	Management	For	For
1.4	Election of Director: C. Raymond Larkin, Jr.	Management	For	For
1.5	Election of Director: George J. Morrow	Management	For	For
1.6	Election of Director: Anne M. Myong	Management	For	For
1.7	Election of Director: Andrea L. Saia	Management	For	For
1.8	Election of Director: Susan E. Siegel	Management	For	For
2.	AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION: Proposal to approve the amendment to our Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.	Management	For	For
3.	ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers.	Management	For	For
4.	ADVISORY VOTE ON FREQUENCY OF STOCKHOLDERS' APPROVAL OF EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Frequency of Stockholders Advisory Vote on Named Executive Officers' Compensation.	Management	1 Year	For
5.	AMENDMENT TO INCENTIVE PLAN: Approve the Amendment to our 2005 Incentive Plan.	Management	For	For
6.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2023.	Management	For	For

AMEDISYS, INC.

Security	023436108	Meeting Type	Annual
Ticker Symbol	AMED	Meeting Date	08-Jun-2023
Record Date	11-Apr-2023

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Richard M. Ashworth		For	For
	2	Vickie L. Capps		For	For
	3	Molly J. Coye, MD		For	For
	4	Julie D. Klapstein		For	For
	5	Teresa L. Kline		For	For
	6	Paul B. Kusserow		For	For
	7	Bruce D. Perkins		For	For
	8	Jeffery A. Rideout, MD		For	For
	9	Ivanetta Davis Samuels		For	For
2.	To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2023.		Management	For	For
3.	To approve, on an advisory (non-binding) basis, the compensation paid to the Company's Named Executive Officers, as set forth in the Company's 2023 Proxy Statement ("Say on Pay" Vote).		Management	For	For
4.	To approve, on an advisory (non-binding) basis, the frequency of future stockholder Say on Pay Votes.		Management	1 Year	For

AMERISOURCEBERGEN CORPORATION

Security	03073E105	Meeting Type	Annual
Ticker Symbol	ABC	Meeting Date	09-Mar-2023
Record Date	09-Jan-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Ornella Barra	Management	For	For
1b.	Election of Director: Steven H. Collis	Management	For	For
1c.	Election of Director: D. Mark Durcan	Management	For	For
1d.	Election of Director: Richard W. Gochnauer	Management	For	For
1e.	Election of Director: Lon R. Greenberg	Management	For	For
1f.	Election of Director: Kathleen W. Hyle	Management	For	For
1g.	Election of Director: Lorence H. Kim, M.D.	Management	For	For
1h.	Election of Director: Henry W. McGee	Management	For	For
1i.	Election of Director: Redonda G. Miller, M.D.	Management	For	For
1j.	Election of Director: Dennis M. Nally	Management	For	For
2.	Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2023.	Management	For	For
3.	Advisory vote to approve the compensation of the Company's named executive officers.	Management	For	For
4.	Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers.	Management	1 Year	For
5.	Shareholder proposal regarding shareholder ratification of termination pay.	Shareholder	Against	For

AMGEN INC.

Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	19-May-2023
Record Date	20-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Wanda M. Austin	Management	For	For
1b.	Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A. Bradway	Management	For	For
1c.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Michael V. Drake	Management	For	For
1d.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Brian J. Druker	Management	For	For
1e.	Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Robert A. Eckert	Management	For	For
1f.	Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Greg C. Garland	Management	For	For
1g.	Election of Director for a term of office expiring at the 2024 annual meeting: Mr. Charles M. Holley, Jr.	Management	For	For
1h.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. S. Omar Ishrak	Management	For	For
1i.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Tyler Jacks	Management	For	For
1j.	Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Ellen J. Kullman	Management	For	For
1k.	Election of Director for a term of office expiring at the 2024 annual meeting: Ms. Amy E. Miles	Management	For	For
1l.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. Ronald D. Sugar	Management	For	For
1m.	Election of Director for a term of office expiring at the 2024 annual meeting: Dr. R. Sanders Williams	Management	For	For
2.	Advisory vote on the frequency of future stockholder advisory votes to approve executive compensation.	Management	1 Year	For
3.	Advisory vote to approve our executive compensation.	Management	For	For
4.	To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2023.	Management	For	For

ARGENX SE

Security	04016X101	Meeting Type	Special
Ticker Symbol	ARGX	Meeting Date	12-Dec-2022
Record Date	08-Nov-2022

Item	Proposal	Proposed by	Vote	For/Against Management
2.	Appointment of Ana Cespedes as non-executive director to the board of directors of the Company	Management	Abstain

ARGENX SE

Security	04016X101	Meeting Type	Annual
Ticker Symbol	ARGX	Meeting Date	02-May-2023
Record Date	04-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
3.	Advisory vote to approve the 2022 remuneration report.	Management	For
4b.	Adoption of the 2022 annual accounts.	Management	For
4d.	Allocation of losses of the Company in the financial year 2021 to the retained earnings of the Company.	Management	For
4e.	Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2022.	Management	For
5.	Proposal to re-appoint Don deBethizy as non-executive director for a term of two years.	Management	For
6.	Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any.	Management	For
7.	Appointment of Deloitte Accountants B.V. as statutory auditor for the 2023 financial year.	Management	For

ARISTEA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	7-Jul-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Appoint Independent director	Management	For	For

ARISTEA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	7-Jul-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Appoint Series A director	Management	For	For

ASSERTIO HOLDINGS, INC.

Security	04546C205	Meeting Type	Annual
Ticker Symbol	ASRT	Meeting Date	10-May-2023
Record Date	31-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to serve until the 2024 Annual Meeting of Stockholders: Heather L. Mason	Management	For	For
1.2	Election of Director to serve until the 2024 Annual Meeting of Stockholders: William T. McKee	Management	For	For
1.3	Election of Director to serve until the 2024 Annual Meeting of Stockholders: Daniel A. Peisert	Management	For	For
1.4	Election of Director to serve until the 2024 Annual Meeting of Stockholders: Peter D. Staple	Management	For	For
1.5	Election of Director to serve until the 2024 Annual Meeting of Stockholders: James L. Tyree	Management	For	For
2.	To approve an amendment and restatement of the Company's Amended and Restated 2014 Omnibus Incentive Plan to increase the number of shares available for issuance thereunder.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the Company's named executive officers.	Management	For	For
4.	To conduct, on an advisory basis, a vote on the preferred frequency of future advisory votes to approve the compensation of the Company's named executive officers.	Management	1 Year	For
5.	To approve an amendment to the Amended and Restated Certificate of Incorporation of Assertio Therapeutics, Inc., a wholly-owned subsidiary of the Company, to eliminate the pass-through voting provision.	Management	For	For
6.	To ratify the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

ASTRAZENECA PLC

Security	046353108	Meeting Type	Annual
Ticker Symbol	AZN	Meeting Date	27-Apr-2023
Record Date	10-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022	Management	For	For
2.	To confirm dividends	Management	For	For
3.	To reappoint PricewaterhouseCoopers LLP as Auditor	Management	For	For
4.	To authorise the Directors to agree the remuneration of the Auditor	Management	For	For
5a.	Re-election of Director: Michel Demaré	Management	For	For
5b.	Re-election of Director: Pascal Soriot	Management	For	For
5c.	Re-election of Director: Aradhana Sarin	Management	For	For
5d.	Re-election of Director: Philip Broadley	Management	For	For
5e.	Re-election of Director: Euan Ashley	Management	For	For
5f.	Re-election of Director: Deborah DiSanzo	Management	For	For
5g.	Re-election of Director: Diana Layfield	Management	For	For
5h.	Re-election of Director: Sheri McCoy	Management	For	For
5i.	Re-election of Director: Tony Mok	Management	For	For
5j.	Re-election of Director: Nazneen Rahman	Management	For	For
5k.	Re-election of Director: Andreas Rummelt	Management	For	For
5l.	Re-election of Director: Marcus Wallenberg	Management	For	For
6.	To approve the Annual Report on Remuneration for the year ended 31 December 2022	Management	For	For
7.	To authorise limited political donations	Management	For	For
8.	To authorise the Directors to allot shares	Management	For	For
9.	To authorise the Directors to disapply pre-emption rights (Special Resolution)	Management	For	For
10.	To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)	Management	For	For
11.	To authorise the Company to purchase its own shares (Special Resolution)	Management	For	For
12.	To reduce the notice period for general meetings (Special Resolution)	Management	For	For
13.	To adopt new Articles of Association (Special Resolution)	Management	For	For

ASTRAZENECA PLC

Security	046353108	Meeting Type	Annual
Ticker Symbol	AZN	Meeting Date	27-Apr-2023
Record Date	04-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022	Management	For	For
2.	To confirm dividends	Management	For	For
3.	To reappoint PricewaterhouseCoopers LLP as Auditor	Management	For	For
4.	To authorise the Directors to agree the remuneration of the Auditor	Management	For	For
5a.	Re-election of Director: Michel Demaré	Management	For	For
5b.	Re-election of Director: Pascal Soriot	Management	For	For
5c.	Re-election of Director: Aradhana Sarin	Management	For	For
5d.	Re-election of Director: Philip Broadley	Management	For	For
5e.	Re-election of Director: Euan Ashley	Management	For	For
5f.	Re-election of Director: Deborah DiSanzo	Management	For	For
5g.	Re-election of Director: Diana Layfield	Management	For	For
5h.	Re-election of Director: Sheri McCoy	Management	For	For
5i.	Re-election of Director: Tony Mok	Management	For	For
5j.	Re-election of Director: Nazneen Rahman	Management	For	For
5k.	Re-election of Director: Andreas Rummelt	Management	For	For
5l.	Re-election of Director: Marcus Wallenberg	Management	For	For
6.	To approve the Annual Report on Remuneration for the year ended 31 December 2022	Management	For	For
7.	To authorise limited political donations	Management	For	For
8.	To authorise the Directors to allot shares	Management	For	For
9.	To authorise the Directors to disapply pre-emption rights (Special Resolution)	Management	For	For
10.	To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)	Management	For	For
11.	To authorise the Company to purchase its own shares (Special Resolution)	Management	For	For
12.	To reduce the notice period for general meetings (Special Resolution)	Management	For	For
13.	To adopt new Articles of Association (Special Resolution)	Management	For	For

AVANTOR, INC.

Security	05352A100	Meeting Type	Annual
Ticker Symbol	AVTR	Meeting Date	11-May-2023
Record Date	17-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Juan Andres	Management	For	For
1b.	Election of Director: John Carethers	Management	For	For
1c.	Election of Director: Lan Kang	Management	For	For
1d.	Election of Director: Joseph Massaro	Management	For	For
1e.	Election of Director: Mala Murthy	Management	For	For
1f.	Election of Director: Jonathan Peacock	Management	For	For
1g.	Election of Director: Michael Severino	Management	For	For
1h.	Election of Director: Christi Shaw	Management	For	For
1i.	Election of Director: Michael Stubblefield	Management	For	For
1j.	Election of Director: Gregory Summe	Management	For	For
2.	Ratification of the Appointment of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2023.	Management	For	For
3.	Approve, on an Advisory Basis, Named Executive Officer Compensation.	Management	For	For

BIOGEN INC.

Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	26-Jun-2023
Record Date	20-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable	Management	For	For
1b.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Caroline D. Dorsa	Management	For	For
1c.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Maria C. Freire	Management	For	For
1d.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: William A. Hawkins	Management	For	For
1e.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable	Management	For	For
1f.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Jesus B. Mantas	Management	For	For
1g.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable	Management	For	For
1h.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Eric K. Rowinsky	Management	For	For
1i.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Stephen A. Sherwin	Management	For	For
1j.	Election of Director to serve for a one-year term extending until the 2024 Annual Meeting: Christopher A. Viehbacher	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	Say on Pay - To approve an advisory vote on executive compensation.	Management	For	For
4.	Say When on Pay - To approve an advisory vote on the frequency of the advisory vote on executive compensation.	Management	1 Year	For
5.	To elect Susan Langer as a director	Management

BOSTON SCIENTIFIC CORPORATION

Security	101137107	Meeting Type	Annual
Ticker Symbol	BSX	Meeting Date	04-May-2023
Record Date	10-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Nelda J. Connors	Management	For	For
1b.	Election of Director: Charles J. Dockendorff	Management	For	For
1c.	Election of Director: Yoshiaki Fujimori	Management	For	For
1d.	Election of Director: Edward J. Ludwig	Management	For	For
1e.	Election of Director: Michael F. Mahoney	Management	For	For
1f.	Election of Director: David J. Roux	Management	For	For
1g.	Election of Director: John E. Sununu	Management	For	For
1h.	Election of Director: David S. Wichmann	Management	For	For
1i.	Election of Director: Ellen M. Zane	Management	For	For
2.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers.	Management	For	For
3.	To approve, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.	Management	1 Year	For
4.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2023 fiscal year.	Management	For	For

BRISTOL-MYERS SQUIBB COMPANY

Security	110122108	Meeting Type	Annual
Ticker Symbol	BMY	Meeting Date	02-May-2023
Record Date	13-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter J. Arduini	Management	For	For
1B.	Election of Director: Deepak L. Bhatt, M.D., M.P.H.	Management	For	For
1C.	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1D.	Election of Director: Julia A. Haller, M.D.	Management	For	For
1E.	Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.	Management	For	For
1F.	Election of Director: Paula A. Price	Management	For	For
1G.	Election of Director: Derica W. Rice	Management	For	For
1H.	Election of Director: Theodore R. Samuels	Management	For	For
1I.	Election of Director: Gerald L. Storch	Management	For	For
1J.	Election of Director: Karen H. Vousden, Ph.D.	Management	For	For
1K.	Election of Director: Phyllis R. Yale	Management	For	For
2.	Advisory Vote to Approve the Compensation of our Named Executive Officers.	Management	For	For
3.	Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers.	Management	1 Year	For
4.	Ratification of the Appointment of an Independent Registered Public Accounting Firm.	Management	For	For
5.	Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director.	Shareholder	For	Against
6.	Shareholder Proposal on Workplace Non-Discrimination Audit.	Shareholder	Against	For
7.	Shareholder Proposal on Special Shareholder Meeting Improvement.	Shareholder	Against	For

CHARLES RIVER LABORATORIES INTL., INC.

Security	159864107	Meeting Type	Annual
Ticker Symbol	CRL	Meeting Date	09-May-2023
Record Date	16-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: James C. Foster	Management	For	For
1b.	Election of Director: Nancy C. Andrews	Management	For	For
1c.	Election of Director: Robert Bertolini	Management	For	For
1d.	Election of Director: Deborah T. Kochevar	Management	For	For
1e.	Election of Director: George Llado, Sr.	Management	For	For
1f.	Election of Director: Martin W. Mackay	Management	For	For
1g.	Election of Director: George E. Massaro	Management	For	For
1h.	Election of Director: C. Richard Reese	Management	For	For
1i.	Election of Director: Craig B. Thompson	Management	For	For
1j.	Election of Director: Richard F. Wallman	Management	For	For
1k.	Election of Director: Virginia M. Wilson	Management	For	For
2.	Advisory Approval of 2022 Executive Officer Compensation	Management	For	For
3.	Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation	Management	1 Year	For
4.	Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2023	Management	For	For
5.	Proposal to publish a report on non-human primates imported by Charles River Laboratories International, Inc.	Management	Against	For

COMMUNITY HEALTH SYSTEMS, INC.

Security	203668108	Meeting Type	Annual
Ticker Symbol	CYH	Meeting Date	09-May-2023
Record Date	13-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Susan W. Brooks	Management	For	For
1b.	Election of Director: John A. Clerico	Management	For	For
1c.	Election of Director: Michael Dinkins	Management	For	For
1d.	Election of Director: James S. Ely III	Management	For	For
1e.	Election of Director: John A. Fry	Management	For	For
1f.	Election of Director: Joseph A. Hastings, D.M.D.	Management	For	For
1g.	Election of Director: Tim L. Hingtgen	Management	For	For
1h.	Election of Director: Elizabeth T. Hirsch	Management	For	For
1i.	Election of Director: William Norris Jennings, M.D.	Management	For	For
1j.	Election of Director: K. Ranga Krishnan, MBBS	Management	For	For
1k.	Election of Director: Wayne T. Smith	Management	For	For
1l.	Election of Director: H. James Williams, Ph.D.	Management	For	For
2.	Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.	Management	For	For
3.	Proposal to approve on an advisory (non-binding) basis the frequency of future advisory votes on the compensation of the Company's named executive officers.	Management	1 Year	For
4.	Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 22, 2023, subject to stockholder approval.	Management	For	For
5.	Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

CVS HEALTH CORPORATION

Security	126650100	Meeting Type	Annual
Ticker Symbol	CVS	Meeting Date	18-May-2023
Record Date	20-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Fernando Aguirre	Management	For	For
1b.	Election of Director: Jeffrey R. Balser, M.D., Ph.D.	Management	For	For
1c.	Election of Director: C. David Brown II	Management	For	For
1d.	Election of Director: Alecia A. DeCoudreaux	Management	For	For
1e.	Election of Director: Nancy-Ann M. DeParle	Management	For	For
1f.	Election of Director: Roger N. Farah	Management	For	For
1g.	Election of Director: Anne M. Finucane	Management	For	For
1h.	Election of Director: Edward J. Ludwig	Management	For	For
1i.	Election of Director: Karen S. Lynch	Management	For	For
1j.	Election of Director: Jean-Pierre Millon	Management	For	For
1k.	Election of Director: Mary L. Schapiro	Management	For	For
2.	Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2023	Management	For	For
3.	Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation	Management	For	For
4.	Proposal to Recommend, on an Advisory Basis, the Frequency of Advisory Votes on Executive Compensation Votes	Management	1 Year	For
5.	Stockholder Proposal Requesting Paid Sick Leave for All Employees	Shareholder	Against	For
6.	Stockholder Proposal for Reducing our Ownership Threshold to Request a Special Stockholder Meeting	Shareholder	Against	For
7.	Stockholder Proposal Regarding "Fair Elections" and Requiring Stockholder Approval of Certain Types of By-law Amendments	Shareholder	Against	For
8.	Stockholder Proposal Requesting a Report on a "Worker Rights Assessment"	Shareholder	Against	For
9.	Stockholder Proposal to Prevent Company Directors from Simultaneously Sitting on the Boards of Directors of Any Other Company	Shareholder	Against	For

DANAHER CORPORATION

Security	235851102	Meeting Type	Annual
Ticker Symbol	DHR	Meeting Date	09-May-2023
Record Date	10-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Rainer M. Blair	Management	For	For
1b.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Feroz Dewan	Management	For	For
1c.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Linda Filler	Management	For	For
1d.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Teri List	Management	For	For
1e.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Walter G. Lohr, Jr.	Management	For	For
1f.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH	Management	For	For
1g.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Mitchell P. Rales	Management	For	For
1h.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Steven M. Rales	Management	For	For
1i.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL	Management	For	For
1j.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: A. Shane Sanders	Management	For	For
1k.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: John T. Schwieters	Management	For	For
1l.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Alan G. Spoon	Management	For	For
1m.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D	Management	For	For
1n.	Election of Director to hold office until the 2024 Annual Meeting of Shareholders: Elias A. Zerhouni, MD	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For
3.	To approve on an advisory basis the Company's named executive officer compensation.	Management	For	For
4.	To hold an advisory vote relating to the frequency of future shareholder advisory votes on the Company's executive officer compensation.	Management	1 Year	For
5.	To act upon a shareholder proposal requesting adoption of a policy separating the chair and CEO roles and requiring an independent Board Chair whenever possible.	Shareholder	For	Against
6.	To act upon a shareholder proposal requesting a report to shareholders on the effectiveness of the Company's diversity, equity and inclusion efforts.	Shareholder	Against	For

DEXCOM, INC.

Security	252131107	Meeting Type	Annual
Ticker Symbol	DXCM	Meeting Date	18-May-2023
Record Date	29-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to hold office until our 2024 Annual Meeting: Steven R. Altman	Management	For	For
1.2	Election of Director to hold office until our 2024 Annual Meeting: Richard A. Collins	Management	For	For
1.3	Election of Director to hold office until our 2024 Annual Meeting: Karen Dahut	Management	For	For
1.4	Election of Director to hold office until our 2024 Annual Meeting: Mark G. Foletta	Management	For	For
1.5	Election of Director to hold office until our 2024 Annual Meeting: Barbara E. Kahn	Management	For	For
1.6	Election of Director to hold office until our 2024 Annual Meeting: Kyle Malady	Management	For	For
1.7	Election of Director to hold office until our 2024 Annual Meeting: Eric J. Topol, M.D.	Management	For	For
2.	To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	To hold a non-binding vote on an advisory resolution to approve executive compensation.	Management	For	For
4.	To recommend a non-binding advisory resolution on the frequency of stockholder votes on executive compensation.	Management	1 Year	For
5.	To hold a non-binding vote on pay equity disclosure.	Management	Against	For

DIVERSIFIED HEALTHCARE TRUST

Security	25525P107	Meeting Type	Annual
Ticker Symbol	DHC	Meeting Date	05-Jun-2023
Record Date	17-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Independent Trustee: John L. Harrington	Management	For	For
1b.	Election of Independent Trustee: Lisa Harris Jones	Management	For	For
1c.	Election of Independent Trustee: Daniel F. LePage	Management	For	For
1d.	Election of Independent Trustee: David A. Pierce	Management	For	For
1e.	Election of Independent Trustee: Jeffrey P. Somers	Management	For	For
1f.	Election of Managing Trustee: Jennifer F. Francis	Management	For	For
1g.	Election of Managing Trustee: Adam D. Portnoy	Management	For	For
2.	Advisory vote to approve executive compensation.	Management	For	For
3.	Advisory vote on the frequency of future advisory votes to approve executive compensation.	Management	1 Year	For
4.	Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2023 fiscal year.	Management	For	For

EDWARDS LIFESCIENCES CORPORATION

Security	28176E108	Meeting Type	Annual
Ticker Symbol	EW	Meeting Date	11-May-2023
Record Date	13-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Kieran T. Gallahue	Management	For	For
1.2	Election of Director: Leslie S. Heisz	Management	For	For
1.3	Election of Director: Paul A. LaViolette	Management	For	For
1.4	Election of Director: Steven R. Loranger	Management	For	For
1.5	Election of Director: Martha H. Marsh	Management	For	For
1.6	Election of Director: Michael A. Mussallem	Management	For	For
1.7	Election of Director: Ramona Sequeira	Management	For	For
1.8	Election of Director: Nicholas J. Valeriani	Management	For	For
1.9	Election of Director: Bernard J. Zovighian	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Advisory Vote to Approve Frequency of Future Advisory Votes on Named Executive Officer Compensation	Management	1 Year	For
4.	Ratification of Appointment of Independent Registered Public Accounting Firm	Management	For	For
5.	Approval of Amendment of the Certificate of Incorporation to Provide for Exculpation of Officers	Management	For	For
6.	Stockholder Proposal regarding Independent Board Chairman Policy	Shareholder	Against	For

ELEVANCE HEALTH, INC.

Security	036752103	Meeting Type	Annual
Ticker Symbol	ELV	Meeting Date	10-May-2023
Record Date	17-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Gail K. Boudreaux	Management	For	For
1b.	Election of Director: R. Kerry Clark	Management	For	For
1c.	Election of Director: Robert L. Dixon, Jr.	Management	For	For
1d.	Election of Director: Deanna D. Strable	Management	For	For
2.	Advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Advisory vote on the frequency of the advisory vote to approve the compensation of our named executive officers.	Management	1 Year	For
4.	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2023.	Management	For	For
5.	Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders.	Shareholder	Against	For
6.	Shareholder proposal requesting annual reporting from third parties seeking financial support.	Shareholder	Against	For

ELI LILLY AND COMPANY

Security	532457108	Meeting Type	Annual
Ticker Symbol	LLY	Meeting Date	01-May-2023
Record Date	21-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to serve a three-year term: William G. Kaelin, Jr.	Management	For	For
1b.	Election of Director to serve a three-year term: David A. Ricks	Management	For	For
1c.	Election of Director to serve a three-year term: Marschall S. Runge	Management	For	For
1d.	Election of Director to serve a three-year term: Karen Walker	Management	For	For
2.	Approval, on an advisory basis, of the compensation paid to the company's named executive officers.	Management	For	For
3.	Advisory vote on frequency of future advisory votes on named executive officer compensation.	Management	1 Year	For
4.	Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2023.	Management	For	For
5.	Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.	Management	For	For
6.	Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.	Management	For	For
7.	Shareholder proposal to publish an annual report disclosing lobbying activities.	Shareholder	Against	For
8.	Shareholder proposal to eliminate supermajority voting requirements.	Shareholder	Against	For
9.	Shareholder proposal to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents.	Shareholder	Against	For
10.	Shareholder proposal to report on risks of supporting abortion.	Shareholder	Against	For
11.	Shareholder proposal to disclose lobbying activities and alignment with public policy positions and statements.	Shareholder	Against	For
12.	Shareholder proposal to report on effectiveness of the company's diversity, equity, and inclusion efforts.	Shareholder	Against	For
13.	Shareholder proposal to adopt a policy to require certain third-party organizations to annually report expenditures for political activities before Lilly contributes to an organization.	Shareholder	Against	For

FUSION PHARMACEUTICALS INC

Security	36118A100	Meeting Type	Annual
Ticker Symbol	FUSN	Meeting Date	14-Jun-2023
Record Date	18-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to serve until the next annual meeting: Donald Bergstrom, M.D., Ph.D.	Management	For	For
1.2	Election of Director to serve until the next annual meeting: Pablo Cagnoni, M.D.	Management	For	For
1.3	Election of Director to serve until the next annual meeting: Johan Christenson, M.D., Ph.D.	Management	For	For
1.4	Election of Director to serve until the next annual meeting: Barbara Duncan	Management	For	For
1.5	Election of Director to serve until the next annual meeting: Steve Gannon	Management	For	For
1.6	Election of Director to serve until the next annual meeting: Chau Khuong	Management	For	For
1.7	Election of Director to serve until the next annual meeting: Philina Lee, Ph.D.	Management	For	For
1.8	Election of Director to serve until the next annual meeting: Heather Preston, M.D.	Management	For	For
1.9	Election of Director to serve until the next annual meeting: John Valliant, Ph.D.	Management	For	For
2.	To appoint PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

GALERA THERAPEUTICS, INC.

Security	36338D108	Meeting Type	Annual
Ticker Symbol	GRTX	Meeting Date	14-Jun-2023
Record Date	21-Apr-2023

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Michael Powell, Ph.D.		For	For
	2	Linda West		For	For
2.	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.		Management	For	For

GILEAD SCIENCES, INC.

Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	03-May-2023
Record Date	15-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Jacqueline K. Barton, Ph.D.	Management	For	For
1b.	Election of Director: Jeffrey A. Bluestone, Ph.D.	Management	For	For
1c.	Election of Director: Sandra J. Horning, M.D.	Management	For	For
1d.	Election of Director: Kelly A. Kramer	Management	For	For
1e.	Election of Director: Kevin E. Lofton	Management	For	For
1f.	Election of Director: Harish Manwani	Management	For	For
1g.	Election of Director: Daniel P. O'Day	Management	For	For
1h.	Election of Director: Javier J. Rodriguez	Management	For	For
1i.	Election of Director: Anthony Welters	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.	Management	For	For
4.	To approve, on an advisory basis, the frequency of future advisory stockholder votes on executive compensation.	Management	1 Year	For
5.	To approve an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and the Gilead Sciences, Inc. International Employee Stock Purchase Plan.	Management	For	For
6.	To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board implement a process to nominate at least one more candidate than the number of directors to be elected.	Shareholder	Against	For
7.	To vote on a stockholder proposal, if properly presented at the meeting, requesting the Board amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting.	Shareholder	Against	For
8.	To vote on a stockholder proposal, if properly presented at the meeting, requesting a report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents.	Shareholder	Against	For

GLOBAL MEDICAL REIT INC.

Security	37954A204	Meeting Type	Annual
Ticker Symbol	GMRE	Meeting Date	10-May-2023
Record Date	15-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to serve until next annual meeting: Jeffrey M. Busch	Management	For	For
1.2	Election of Director to serve until next annual meeting: Matthew Cypher	Management	For	For
1.3	Election of Director to serve until next annual meeting: Ronald Marston	Management	For	For
1.4	Election of Director to serve until next annual meeting: Henry E. Cole	Management	For	For
1.5	Election of Director to serve until next annual meeting: Zhang Huiqi	Management	For	For
1.6	Election of Director to serve until next annual meeting: Paula R. Crowley	Management	For	For
1.7	Election of Director to serve until next annual meeting: Lori Wittman	Management	For	For
2.	Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement.	Management	For	For
3.	To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For

GUARDANT HEALTH, INC.

Security	40131M109	Meeting Type	Annual
Ticker Symbol	GH	Meeting Date	14-Jun-2023
Record Date	17-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Class II Director: Ian Clark	Management	For	For
1b.	Election of Class II Director: Meghan Joyce	Management	For	For
1c.	Election of Class II Director: Samir Kaul	Management	For	For
2.	Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For
3.	Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.	Management	For	For

HCA HEALTHCARE, INC.

Security	40412C101	Meeting Type	Annual
Ticker Symbol	HCA	Meeting Date	19-Apr-2023
Record Date	24-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Thomas F. Frist III	Management	For	For
1b.	Election of Director: Samuel N. Hazen	Management	For	For
1c.	Election of Director: Meg G. Crofton	Management	For	For
1d.	Election of Director: Robert J. Dennis	Management	For	For
1e.	Election of Director: Nancy-Ann DeParle	Management	For	For
1f.	Election of Director: William R. Frist	Management	For	For
1g.	Election of Director: Hugh F. Johnston	Management	For	For
1h.	Election of Director: Michael W. Michelson	Management	For	For
1i.	Election of Director: Wayne J. Riley, M.D.	Management	For	For
1j.	Election of Director: Andrea B. Smith	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For
3.	To approve the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan.	Management	For	For
4.	Advisory vote to approve named executive officer compensation.	Management	For	For
5.	Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure.	Shareholder	Against	For
6.	Stockholder proposal, if properly presented at the meeting, regarding amendment to Patient Safety and Quality of Care Committee charter.	Shareholder	Against	For

HEALTHCARE REALTY TRUST INCORPORATED

Security	42226K105	Meeting Type	Annual
Ticker Symbol	HR	Meeting Date	05-Jun-2023
Record Date	14-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Todd J. Meredith	Management	For	For
1b.	Election of Director: John V. Abbott	Management	For	For
1c.	Election of Director: Nancy H. Agee	Management	For	For
1d.	Election of Director: W. Bradley Blair II	Management	For	For
1e.	Election of Director: Vicki U. Booth	Management	For	For
1f.	Election of Director: Edward H. Braman	Management	For	For
1g.	Election of Director: Ajay Gupta	Management	For	For
1h.	Election of Director: James J. Kilroy	Management	For	For
1i.	Election of Director: Jay P. Leupp	Management	For	For
1j.	Election of Director: Peter F. Lyle	Management	For	For
1k.	Election of Director: Constance B. Moore	Management	For	For
1l.	Election of Director: John Knox Singleton	Management	For	For
1m.	Election of Director: Christann M. Vasquez	Management	For	For
2.	To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2023 fiscal year.	Management	For	For
3.	To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2023 Annual Meeting of Stockholders.	Management	For	For
4.	To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on executive compensation.	Management	1 Year	For

HEALTHCARE TRUST OF AMERICA, INC.

Security	42225P501	Meeting Type	Special
Ticker Symbol	HTA	Meeting Date	15-Jul-2022
Record Date	10-Jun-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Company Issuance Proposal. To approve the issuance of shares of class A common stock, $0.01 par value per share ("Company Common Stock"), of Healthcare Trust of America, Inc. (the "Company"), pursuant to the Agreement and Plan of Merger, dated as of February 28, 2022, by and among the Company, Healthcare Trust of America Holdings, LP, Healthcare Realty Trust Incorporated, and HR Acquisition 2, LLC (the "Merger").	Management	For	For
2.	Company Golden Parachute Proposal. To approve, in a non-binding advisory vote, the "golden parachute" compensation that may become vested and payable to the Company's named executive officers in connection with the Merger.	Management	For	For
3.	Company Adjournment Proposal. To approve one or more adjournments of the Company Special Meeting to another date, time, place, or format, if necessary or appropriate, including to solicit additional proxies in favor of the proposal to approve the issuance of shares of Company Common Stock in connection with the Merger.	Management	For	For

HEALTHPEAK PROPERTIES, INC

Security	42250P103	Meeting Type	Annual
Ticker Symbol	PEAK	Meeting Date	27-Apr-2023
Record Date	01-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Scott M. Brinker	Management	For	For
1b.	Election of Director: Brian G. Cartwright	Management	For	For
1c.	Election of Director: James B. Connor	Management	For	For
1d.	Election of Director: Christine N. Garvey	Management	For	For
1e.	Election of Director: R. Kent Griffin, Jr.	Management	For	For
1f.	Election of Director: David B. Henry	Management	For	For
1g.	Election of Director: Sara G. Lewis	Management	For	For
1h.	Election of Director: Katherine M. Sandstrom	Management	For	For
2.	Approval of 2022 executive compensation on an advisory basis.	Management	For	For
3.	Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation.	Management	1 Year	For
4.	Approval of the Healthpeak Properties, Inc. 2023 Performance Incentive Plan.	Management	For	For
5.	Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For

HORIZON THERAPEUTICS PLC

Security	G46188101	Meeting Type	Special
Ticker Symbol	HZNP	Meeting Date	24-Feb-2023
Record Date	19-Jan-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary Resolution to approve the Scheme of Arrangement and authorize the directors of Horizon to take all such actions as they consider necessary or appropriate for carrying the Scheme of Arrangement into effect.	Management	For	For
2.	Special Resolution to amend the articles of association of Horizon so that any Horizon Shares that are issued on or after the Voting Record Time to persons other than Acquirer Sub or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or be immediately and automatically acquired by Acquirer Sub and/or its nominee(s) for the Scheme Consideration.	Management	For	For
3.	Ordinary Resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Horizon and its named executive officers relating to the Transaction.	Management	For	For
4.	Ordinary Resolution to approve any motion by the Chairman to adjourn the EGM or any adjournments thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of the EGM to approve resolutions 1 and 2.	Management	For	For

HORIZON THERAPEUTICS PLC

Security	G46188111	Meeting Type	Special
Ticker Symbol	HZNP	Meeting Date	24-Feb-2023
Record Date	19-Jan-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.	That the Scheme of Arrangement in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to.	Management	For	For

HUMANA INC.

Security	444859102	Meeting Type	Annual
Ticker Symbol	HUM	Meeting Date	20-Apr-2023
Record Date	28-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a)	Election of Director: Raquel C. Bono, M.D.	Management	For	For
1b)	Election of Director: Bruce D. Broussard	Management	For	For
1c)	Election of Director: Frank A. D'Amelio	Management	For	For
1d)	Election of Director: David T. Feinberg, M.D.	Management	For	For
1e)	Election of Director: Wayne A. I. Frederick, M.D.	Management	For	For
1f)	Election of Director: John W. Garratt	Management	For	For
1g)	Election of Director: Kurt J. Hilzinger	Management	For	For
1h)	Election of Director: Karen W. Katz	Management	For	For
1i)	Election of Director: Marcy S. Klevorn	Management	For	For
1j)	Election of Director: William J. McDonald	Management	For	For
1k)	Election of Director: Jorge S. Mesquita	Management	For	For
1l)	Election of Director: Brad D. Smith	Management	For	For
2.	The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.	Management	For	For
3.	Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2023 proxy statement.	Management	For	For
4.	Non-binding advisory vote for the approval of the frequency with which future stockholder votes on the compensation of the named executive officers will be held.	Management	1 Year	For

ICON PLC

Security	G4705A100	Meeting Type	Annual
Ticker Symbol	ICLR	Meeting Date	26-Jul-2022
Record Date	06-Jun-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Dr. Steve Cutler	Management	For	For
1.2	Election of Director: Dr. John Climax	Management	For	For
1.3	Election of Director: Mr. Ronan Murphy	Management	For	For
2.	To review the Company's affairs and consider the Accounts and Reports	Management	For	For
3.	To authorise the fixing of the Auditors' Remuneration	Management	For	For
4.	To authorise the Company to allot shares	Management	For	For
5.	To disapply the statutory pre-emption rights	Management	For	For
6.	To disapply the statutory pre-emption rights for funding capital investment or acquisitions	Management	For	For
7.	To authorise the Company to make market purchases of shares	Management	For	For
8.	To authorise the price range at which the Company can reissue shares that it holds as treasury shares	Management	For	For

IDEXX LABORATORIES, INC.

Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	17-May-2023
Record Date	20-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director (Proposal One): Daniel M. Junius	Management	For	For
1b.	Election of Director (Proposal One): Lawrence D. Kingsley	Management	For	For
1c.	Election of Director (Proposal One): Sophie V. Vandebroek, PhD	Management	For	For
2.	Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).	Management	For	For
3.	Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).	Management	For	For
4.	Advisory Vote on the Frequency of Advisory Votes on Executive Compensation. To recommend, by nonbinding advisory vote, the frequency of future advisory votes on the Company's executive compensation (Proposal Four).	Management	1 Year	For

ILLUMINA, INC.

Security	452327109	Meeting Type	Contested-Annual
Ticker Symbol	ILMN	Meeting Date	25-May-2023
Record Date	03-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Illumina Nominee: Frances Arnold, Ph.D.	Management	For	For
1B.	Illumina Nominee: Francis A. deSouza	Management	Withheld	For
1C.	Illumina Nominee: Caroline D. Dorsa	Management	Withheld	For
1D.	Illumina Nominee: Robert S. Epstein, M.D.	Management	Withheld	For
1E.	Illumina Nominee: Scott Gottlieb, M.D.	Management	For	For
1F.	Illumina Nominee: Gary S. Guthart, Ph.D.	Management	Withheld	For
1G.	Illumina Nominee: Philip W. Schiller	Management	For	For
1H.	Illumina Nominee: Susan E. Siegel	Management	For	For
1I.	Illumina Nominee: John W. Thompson	Management	Withheld	For
1J.	Icahn Group Nominee OPPOSED by the Company: Vincent J. Intrieri	Management	For	For
1K.	Icahn Group Nominee OPPOSED by the Company: Jesse A. Lynn	Management	Withheld	For
1L.	Icahn Group Nominee OPPOSED by the Company: Andrew J. Teno	Management	Withheld	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	To approve, on an advisory basis, the compensation provided to our named executive officers as disclosed in the Proxy Statement.	Management	Against	Against
4.	To approve, on an advisory basis, the frequency of holding an advisory vote to approve compensation provided to our "named executive officers".	Management	1 Year	For
5.	To approve certain amendments to the Illumina, Inc. 2015 Stock and Incentive Plan	Management	For	For

INTUITIVE SURGICAL, INC.

Security	46120E602	Meeting Type	Annual
Ticker Symbol	ISRG	Meeting Date	27-Apr-2023
Record Date	28-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Craig H. Barratt, Ph.D.	Management	For	For
1b.	Election of Director: Joseph C. Beery	Management	For	For
1c.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1d.	Election of Director: Amal M. Johnson	Management	For	For
1e.	Election of Director: Don R. Kania, Ph.D.	Management	For	For
1f.	Election of Director: Amy L. Ladd, M.D.	Management	For	For
1g.	Election of Director: Keith R. Leonard, Jr.	Management	For	For
1h.	Election of Director: Alan J. Levy, Ph.D.	Management	For	For
1i.	Election of Director: Jami Dover Nachtsheim	Management	For	For
1j.	Election of Director: Monica P. Reed, M.D.	Management	For	For
1k.	Election of Director: Mark J. Rubash	Management	For	For
2.	To approve, by advisory vote, the compensation of the Company's Named Executive Officers	Management	For	For
3.	To approve, by advisory vote, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers.	Management	1 Year	For
4.	The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
5.	The stockholder proposal regarding pay equity disclosure.	Shareholder	Against	For

IO LIGHT HOLDINGS, INC

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	27-Sep-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of Subsidiary Transfer Documents	Management	For	For
2.	General Resolutions	Management	For	For

IO LIGHT HOLDINGS, INC

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	30-Dec-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of Series B Financing	Management	For	For
2.	Approval of Amended and Restated Certification of Incorporation	Management	For	For
3.	Approval of Amended and Restated Stockholders Agreement	Management	For	For

IQVIA HOLDINGS INC.

Security	46266C105	Meeting Type	Annual
Ticker Symbol	IQV	Meeting Date	18-Apr-2023
Record Date	17-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Carol J. Burt	Management	For	For
1b.	Election of Director: Colleen A. Goggins	Management	For	For
1c.	Election of Director: Sheila A. Stamps	Management	For	For
2.	Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).	Management	For	For
3.	Approve a Company proposal to amend IQVIA's Certificate of Incorporation to adopt a stockholders' right to request a special stockholders' meeting.	Management	For	For
4.	If properly presented, a stockholder proposal concerning special stockholder meetings.	Shareholder	For	Against
5.	If properly presented, a stockholder proposal for separate Chairman and Chief Executive Officer roles.	Shareholder	For	Against
6.	Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2023.	Management	For	For

JAZZ PHARMACEUTICALS PLC

Security	G50871105	Meeting Type	Annual
Ticker Symbol	JAZZ	Meeting Date	28-Jul-2022
Record Date	01-Jun-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to hold office until the 2025 Annual General Meeting: Jennifer E. Cook	Management	For	For
1b.	Election of Director to hold office until the 2025 Annual General Meeting: Patrick G. Enright	Management	For	For
1c.	Election of Director to hold office until the 2025 Annual General Meeting: Seamus Mulligan	Management	For	For
1d.	Election of Director to hold office until the 2025 Annual General Meeting: Norbert G. Riedel, Ph.D.	Management	For	For
2.	To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2022 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.	Management	For	For
4.	To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply.	Management	For	For
5.	To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 4.	Management	For	For

JOHNSON & JOHNSON

Security	478160104	Meeting Type	Annual
Ticker Symbol	JNJ	Meeting Date	27-Apr-2023
Record Date	28-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Darius Adamczyk	Management	For	For
1b.	Election of Director: Mary C. Beckerle	Management	For	For
1c.	Election of Director: D. Scott Davis	Management	For	For
1d.	Election of Director: Jennifer A. Doudna	Management	For	For
1e.	Election of Director: Joaquin Duato	Management	For	For
1f.	Election of Director: Marillyn A. Hewson	Management	For	For
1g.	Election of Director: Paula A. Johnson	Management	For	For
1h.	Election of Director: Hubert Joly	Management	For	For
1I.	Election of Director: Mark B. McClellan	Management	For	For
1j.	Election of Director: Anne M. Mulcahy	Management	For	For
1k.	Election of Director: Mark A. Weinberger	Management	For	For
1l.	Election of Director: Nadja Y. West	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation	Management	1 Year	For
4.	Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm	Management	For	For
5.	Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw)	Shareholder	Abstain
6.	Vaccine Pricing Report	Shareholder	Against	For
7.	Executive Compensation Adjustment Policy	Shareholder	Against	For
8.	Impact of Extended Patent Exclusivities on Product Access	Shareholder	Against	For

LABORATORY CORP. OF AMERICA HOLDINGS

Security	50540R409	Meeting Type	Annual
Ticker Symbol	LH	Meeting Date	11-May-2023
Record Date	16-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kerrii B. Anderson	Management	For	For
1b.	Election of Director: Jean-Luc Bélingard	Management	For	For
1c.	Election of Director: Jeffrey A. Davis	Management	For	For
1d.	Election of Director: D. Gary Gilliland, M.D., Ph.D.	Management	For	For
1e.	Election of Director: Kirsten M. Kliphouse	Management	For	For
1f.	Election of Director: Garheng Kong, M.D., Ph.D.	Management	For	For
1g.	Election of Director: Peter M. Neupert	Management	For	For
1h.	Election of Director: Richelle P. Parham	Management	For	For
1i.	Election of Director: Adam H. Schechter	Management	For	For
1j.	Election of Director: Kathryn E. Wengel	Management	For	For
1k.	Election of Director: R. Sanders Williams, M.D.	Management	For	For
2.	To approve, by non-binding vote, executive compensation.	Management	For	For
3.	To recommend by non-binding vote, the frequency of future non-binding votes on executive compensation.	Management	1 Year	For
4.	Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For
5.	Shareholder proposal relating to a policy regarding separation of the roles of Board Chairman and Chief Executive Officer.	Shareholder	For	Against
6.	Shareholder proposal regarding a Board report on transport of nonhuman primates within the U.S.	Shareholder	Against	For
7.	Shareholder proposal regarding a Board report on known risks of fulfilling information requests and mitigation strategies.	Shareholder	Against	For

LANTHEUS HOLDINGS, INC.

Security	516544103	Meeting Type	Annual
Ticker Symbol	LNTH	Meeting Date	27-Apr-2023
Record Date	06-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Class II Director: Ms. Minnie Baylor-Henry	Management	For	For
1.2	Election of Class II Director: Mr. Heinz Mäusli	Management	For	For
1.3	Election of Class II Director: Ms. Julie McHugh	Management	For	For
2.	The approval, on an advisory basis, of the compensation paid to our named executive officers.	Management	For	For
3.	The approval of the Lantheus Holdings, Inc. 2023 Employee Stock Purchase Plan.	Management	For	For
4.	The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

LIVANOVA PLC

Security	G5509L101	Meeting Type	Annual
Ticker Symbol	LIVN	Meeting Date	12-Jun-2023
Record Date	21-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Francesco Bianchi	Management	For	For
1b.	Election of Director: Stacy Enxing Seng	Management	For	For
1c.	Election of Director: William Kozy	Management	For	For
1d.	Election of Director: Daniel Moore	Management	For	For
1e.	Election of Director: Dr. Sharon O'Kane	Management	For	For
1f.	Election of Director: Andrea Saia	Management	For	For
1g.	Election of Director: Todd Schermerhorn	Management	For	For
1h.	Election of Director: Brooke Story	Management	For	For
1i.	Election of Director: Peter Wilver	Management	For	For
2.	Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say-on-Pay").	Management	For	For
3.	Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2023.	Management	For	For
4.	Ordinary Resolution: To approve the Amended and Restated LivaNova PLC 2022 Incentive Award Plan.	Management	For	For
5.	Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act") to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of £10,770,848, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end ...(due to space limits, see proxy material for full proposal).	Management	For	For
6.	Special Resolution: Subject to the passing of resolution 5 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 5, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' ...(due to space limits, see proxy material for full proposal).	Management	For	For
7.	Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the period ended December 31, 2022.	Management	For	For
8.	Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2022, together with the reports of the directors and auditors thereon.	Management	For	For
9.	Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2023.	Management	For	For
10.	Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor.	Management	For	For

LTC PROPERTIES, INC.

Security	502175102	Meeting Type	Annual
Ticker Symbol	LTC	Meeting Date	24-May-2023
Record Date	10-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Cornelia Cheng	Management	For	For
1b.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Boyd W. Hendrickson	Management	For	For
1c.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: James J. Pieczynski	Management	For	For
1d.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Devra G. Shapiro	Management	For	For
1e.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Wendy L. Simpson	Management	For	For
1f.	Election of Director to hold office until the 2024 Annual Meeting of Stockholders: Timothy J. Triche	Management	For	For
2.	Ratification of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Advisory vote on the frequency of the advisory vote on executive compensation.	Management	1 Year	For

MCKESSON CORPORATION

Security	58155Q103	Meeting Type	Annual
Ticker Symbol	MCK	Meeting Date	22-Jul-2022
Record Date	27-May-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director for a one-year term: Richard H. Carmona, M.D.	Management	For	For
1b.	Election of Director for a one-year term: Dominic J. Caruso	Management	For	For
1c.	Election of Director for a one-year term: W. Roy Dunbar	Management	For	For
1d.	Election of Director for a one-year term: James H. Hinton	Management	For	For
1e.	Election of Director for a one-year term: Donald R. Knauss	Management	For	For
1f.	Election of Director for a one-year term: Bradley E. Lerman	Management	For	For
1g.	Election of Director for a one-year term: Linda P. Mantia	Management	For	For
1h.	Election of Director for a one-year term: Maria Martinez	Management	For	For
1i.	Election of Director for a one-year term: Susan R. Salka	Management	For	For
1j.	Election of Director for a one-year term: Brian S. Tyler	Management	For	For
1k.	Election of Director for a one-year term: Kathleen Wilson-Thompson	Management	For	For
2.	Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023.	Management	For	For
3.	Advisory vote on executive compensation.	Management	For	For
4.	Approval of our 2022 Stock Plan.	Management	For	For
5.	Approval of Amendment to our 2000 Employee Stock Purchase Plan.	Management	For	For
6.	Shareholder Proposal on Special Shareholder Meeting Improvement.	Shareholder	Against	For
7.	Shareholder Proposal on Transparency in Rule 10b5-1 Trading Policy.	Shareholder	Against	For

MEDICAL PROPERTIES TRUST, INC.

Security	58463J304	Meeting Type	Annual
Ticker Symbol	MPW	Meeting Date	25-May-2023
Record Date	29-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Edward K. Aldag, Jr.	Management	For	For
1.2	Election of Director: G. Steven Dawson	Management	For	For
1.3	Election of Director: R. Steven Hamner	Management	For	For
1.4	Election of Director: Caterina A. Mozingo	Management	For	For
1.5	Election of Director: Emily W. Murphy	Management	For	For
1.6	Election of Director: Elizabeth N. Pitman	Management	For	For
1.7	Election of Director: D. Paul Sparks, Jr.	Management	For	For
1.8	Election of Director: Michael G. Stewart	Management	For	For
1.9	Election of Director: C. Reynolds Thompson, III	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.	Management	For	For
4.	To recommend, on a non-binding, advisory basis, the frequency of future advisory votes on executive compensation.	Management	1 Year	For

MEDTRONIC PLC

Security	G5960L103	Meeting Type	Annual
Ticker Symbol	MDT	Meeting Date	08-Dec-2022
Record Date	11-Oct-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to hold office until the 2023 Annual General Meeting: Richard H. Anderson	Management	For	For
1b.	Election of Director to hold office until the 2023 Annual General Meeting: Craig Arnold	Management	For	For
1c.	Election of Director to hold office until the 2023 Annual General Meeting: Scott C. Donnelly	Management	For	For
1d.	Election of Director to hold office until the 2023 Annual General Meeting: Lidia L. Fonseca	Management	For	For
1e.	Election of Director to hold office until the 2023 Annual General Meeting: Andrea J. Goldsmith, Ph.D.	Management	For	For
1f.	Election of Director to hold office until the 2023 Annual General Meeting: Randall J. Hogan, III	Management	For	For
1g.	Election of Director to hold office until the 2023 Annual General Meeting: Kevin E. Lofton	Management	For	For
1h.	Election of Director to hold office until the 2023 Annual General Meeting: Geoffrey S. Martha	Management	For	For
1i.	Election of Director to hold office until the 2023 Annual General Meeting: Elizabeth G. Nabel, M.D.	Management	For	For
1j.	Election of Director to hold office until the 2023 Annual General Meeting: Denise M. O'Leary	Management	For	For
1k.	Election of Director to hold office until the 2023 Annual General Meeting: Kendall J. Powell	Management	For	For
2.	Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2023 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.	Management	For	For
3.	Approving, on an advisory basis, the Company's executive compensation.	Management	For	For
4.	Renewing the Board of Directors' authority to issue shares under Irish law.	Management	For	For
5.	Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law.	Management	For	For
6.	Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.	Management	For	For

MERCK & CO., INC.

Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	23-May-2023
Record Date	24-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Douglas M. Baker, Jr.	Management	For	For
1b.	Election of Director: Mary Ellen Coe	Management	For	For
1c.	Election of Director: Pamela J. Craig	Management	For	For
1d.	Election of Director: Robert M. Davis	Management	For	For
1e.	Election of Director: Thomas H. Glocer	Management	For	For
1f.	Election of Director: Risa J. Lavizzo-Mourey, M.D.	Management	For	For
1g.	Election of Director: Stephen L. Mayo, Ph.D.	Management	For	For
1h.	Election of Director: Paul B. Rothman, M.D.	Management	For	For
1i.	Election of Director: Patricia F. Russo	Management	For	For
1j.	Election of Director: Christine E. Seidman, M.D.	Management	For	For
1k.	Election of Director: Inge G. Thulin	Management	For	For
1l.	Election of Director: Kathy J. Warden	Management	For	For
1m.	Election of Director: Peter C. Wendell	Management	For	For
2.	Non-binding advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Non-binding advisory vote to approve the frequency of future votes to approve the compensation of our named executive officers.	Management	1 Year	For
4.	Ratification of the appointment of the Company's independent registered public accounting firm for 2023.	Management	For	For
5.	Shareholder proposal regarding business operations in China.	Shareholder	Against	For
6.	Shareholder proposal regarding access to COVID-19 products.	Shareholder	Against	For
7.	Shareholder proposal regarding indirect political spending.	Shareholder	Against	For
8.	Shareholder proposal regarding patents and access.	Shareholder	Against	For
9.	Shareholder proposal regarding a congruency report of partnerships with globalist organizations.	Shareholder	Against	For
10.	Shareholder proposal regarding an independent board chairman.	Shareholder	For	Against

MODERNA, INC.

Security	60770K107	Meeting Type	Annual
Ticker Symbol	MRNA	Meeting Date	03-May-2023
Record Date	08-Mar-2023

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Stephen Berenson		For	For
	2	Sandra Horning, M.D.		For	For
	3	Paul Sagan		For	For
2.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers.		Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2023.		Management	For	For
4.	To vote on a shareholder proposal requesting a report on transferring intellectual property.		Shareholder	Against	For

MOLINA HEALTHCARE, INC.

Security	60855R100	Meeting Type	Annual
Ticker Symbol	MOH	Meeting Date	03-May-2023
Record Date	08-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to hold office until the 2024 Annual Meeting: Barbara L. Brasier	Management	For	For
1b.	Election of Director to hold office until the 2024 Annual Meeting: Daniel Cooperman	Management	For	For
1c.	Election of Director to hold office until the 2024 Annual Meeting: Stephen H. Lockhart	Management	For	For
1d.	Election of Director to hold office until the 2024 Annual Meeting: Steven J. Orlando	Management	For	For
1e.	Election of Director to hold office until the 2024 Annual Meeting: Ronna E. Romney	Management	For	For
1f.	Election of Director to hold office until the 2024 Annual Meeting: Richard M. Schapiro	Management	For	For
1g.	Election of Director to hold office until the 2024 Annual Meeting: Dale B. Wolf	Management	For	For
1h.	Election of Director to hold office until the 2024 Annual Meeting: Richard C. Zoretic	Management	For	For
1i.	Election of Director to hold office until the 2024 Annual Meeting: Joseph M. Zubretsky	Management	For	For
2.	To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.	Management	For	For
3.	To conduct an advisory vote on the frequency of a stockholder vote on the compensation of our named executive officers.	Management	1 Year	For
4.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023.	Management	For	For

NATIONAL HEALTH INVESTORS, INC.

Security	63633D104	Meeting Type	Annual
Ticker Symbol	NHI	Meeting Date	05-May-2023
Record Date	10-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: W. Andrew Adams	Management	For	For
1b.	Election of Director: Tracy M.J. Colden	Management	For	For
1c.	Election of Director: Robert A. McCabe, Jr.	Management	For	For
2.	Approve the Amended and Restated 2019 Stock Incentive Plan.	Management	For	For
3.	Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement.	Management	For	For
4.	Approve the advisory vote on the frequency of the advisory vote on the compensation of the named executive officers.	Management	1 Year	For
5.	Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2023.	Management	For	For

OCULIS HOLDING AG

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	8-Jul-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Change of Designation of the Existing Series C Preferred Shares and Revision of the Articles of Association	Management	For	For
2.	Ordinary Share Capital Increase	Management	For	For
3.	Conditional Share Capital Increase	Management	For	For
4.	Election of Member to the Board of Directors	Management	For	For

OMEGA HEALTHCARE INVESTORS, INC.

Security	681936100	Meeting Type	Annual
Ticker Symbol	OHI	Meeting Date	05-Jun-2023
Record Date	06-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kapila K. Anand	Management	For	For
1b.	Election of Director: Craig R. Callen	Management	For	For
1c.	Election of Director: Dr. Lisa C. Egbuonu-Davis	Management	For	For
1d.	Election of Director: Barbara B. Hill	Management	For	For
1e.	Election of Director: Kevin J. Jacobs	Management	For	For
1f.	Election of Director: C. Taylor Pickett	Management	For	For
1g.	Election of Director: Stephen D. Plavin	Management	For	For
1h.	Election of Director: Burke W. Whitman	Management	For	For
2.	Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2023.	Management	For	For
3.	Approval, on an Advisory Basis, of Executive Compensation.	Management	For	For
4.	Advisory Vote on Frequency of Advisory Votes on Executive Compensation.	Management	1 Year	For
5.	Approval of Amendment to the Omega Healthcare Investors, Inc. 2018 Stock Incentive Plan to increase the number of shares of Common Stock authorized for issuance thereunder.	Management	For	For

OPTION CARE HEALTH, INC.

Security	68404L201	Meeting Type	Annual
Ticker Symbol	OPCH	Meeting Date	17-May-2023
Record Date	22-Mar-2023

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	John J. Arlotta		For	For
	2	Elizabeth Q. Betten		For	For
	3	Elizabeth D. Bierbower		For	For
	4	Natasha Deckmann		For	For
	5	David W. Golding		For	For
	6	Harry M. J. Kraemer Jr.		For	For
	7	R. Carter Pate		For	For
	8	John C. Rademacher		For	For
	9	Nitin Sahney		For	For
	10	Timothy P. Sullivan		For	For
2.	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2023.		Management	For	For
3.	To approve, on a non-binding advisory basis, our executive compensation.		Management	For	For
4.	To conduct an advisory vote on the frequency of a stockholder vote on our executive compensation.		Management	1 Year	For

PERRIGO COMPANY PLC

Security	G97822103	Meeting Type	Annual
Ticker Symbol	PRGO	Meeting Date	04-May-2023
Record Date	06-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to hold office until the 2024 Annual General Meeting: Bradley A. Alford	Management	For	For
1B.	Election of Director to hold office until the 2024 Annual General Meeting: Orlando D. Ashford	Management	For	For
1C.	Election of Director to hold office until the 2024 Annual General Meeting: Katherine C. Doyle	Management	For	For
1D.	Election of Director to hold office until the 2024 Annual General Meeting: Adriana Karaboutis	Management	For	For
1E.	Election of Director to hold office until the 2024 Annual General Meeting: Murray S. Kessler	Management	For	For
1F.	Election of Director to hold office until the 2024 Annual General Meeting: Jeffrey B. Kindler	Management	For	For
1G.	Election of Director to hold office until the 2024 Annual General Meeting: Erica L. Mann	Management	For	For
1H.	Election of Director to hold office until the 2024 Annual General Meeting: Albert A. Manzone	Management	For	For
1I.	Election of Director to hold office until the 2024 Annual General Meeting: Donal O'Connor	Management	For	For
1J.	Election of Director to hold office until the 2024 Annual General Meeting: Geoffrey M. Parker	Management	For	For
2.	Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor	Management	For	For
3.	Advisory vote on executive compensation	Management	For	For
4.	Advisory vote on the frequency of future advisory votes on executive compensation	Management	1 Year	For
5.	Renew the Board's authority to issue shares under Irish law	Management	For	For
6.	Renew the Board's authority to opt-out of statutory pre-emption rights under Irish law	Management	For	For
7.	Approve the creation of distributable reserves by reducing some or all of the Company's share premium	Management	For	For

PFIZER INC.

Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	27-Apr-2023
Record Date	01-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Ronald E. Blaylock	Management	For	For
1b.	Election of Director: Albert Bourla	Management	For	For
1c.	Election of Director: Susan Desmond-Hellmann	Management	For	For
1d.	Election of Director: Joseph J. Echevarria	Management	For	For
1e.	Election of Director: Scott Gottlieb	Management	For	For
1f.	Election of Director: Helen H. Hobbs	Management	For	For
1g.	Election of Director: Susan Hockfield	Management	For	For
1h.	Election of Director: Dan R. Littman	Management	For	For
1i.	Election of Director: Shantanu Narayen	Management	For	For
1j.	Election of Director: Suzanne Nora Johnson	Management	For	For
1k.	Election of Director: James Quincey	Management	For	For
1l.	Election of Director: James C. Smith	Management	For	For
2.	Ratify the selection of KPMG LLP as independent registered public accounting firm for 2023	Management	For	For
3.	2023 advisory approval of executive compensation	Management	For	For
4.	Advisory vote on frequency of future advisory votes to approve executive compensation	Management	1 Year	For
5.	Shareholder proposal regarding ratification of termination pay	Shareholder	Against	For
6.	Shareholder proposal regarding independent board chairman policy	Shareholder	For	Against
7.	Shareholder proposal regarding transfer of intellectual property to potential COVID-19 manufacturers feasibility report	Shareholder	Against	For
8.	Shareholder proposal regarding impact of extended patent exclusivities on product access report	Shareholder	Against	For
9.	Shareholder proposal regarding political contributions congruency report	Shareholder	Against	For

PHYSICIANS REALTY TRUST

Security	71943U104	Meeting Type	Annual
Ticker Symbol	DOC	Meeting Date	03-May-2023
Record Date	24-Feb-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Trustee: John T. Thomas	Management	For	For
1.2	Election of Trustee: Tommy G. Thompson	Management	For	For
1.3	Election of Trustee: Stanton D. Anderson	Management	For	For
1.4	Election of Trustee: Mark A. Baumgartner	Management	For	For
1.5	Election of Trustee: Albert C. Black, Jr.	Management	For	For
1.6	Election of Trustee: William A. Ebinger, M.D.	Management	For	For
1.7	Election of Trustee: Pamela J. Kessler	Management	For	For
1.8	Election of Trustee: Ava E. Lias-Booker	Management	For	For
1.9	Election of Trustee: Richard A. Weiss	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.	Management	For	For
4.	To approve the Amended and Restated Physicians Realty Trust 2013 Equity Incentive Plan.	Management	For	For
5.	To approve the Amended and Restated Physicians Realty Trust 2015 Employee Stock Purchase Plan.	Management	For	For

R1 RCM INC.

Security	77634L105	Meeting Type	Annual
Ticker Symbol	RCM	Meeting Date	17-May-2023
Record Date	21-Mar-2023

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	B. Kyle Armbrester		For	For
	2	Agnes Bundy Scanlan		For	For
	3	Brian K. Dean		For	For
	4	Jeremy Delinsky		For	For
	5	David M. Dill		For	For
	6	Michael C. Feiner		For	For
	7	Joseph Flanagan		For	For
	8	John B. Henneman III		For	For
	9	Matthew Holt		For	For
	10	Neal Moszkowski		For	For
	11	Lee Rivas		For	For
	12	Ian Sacks		For	For
	13	Jill Smith		For	For
	14	Anthony J. Speranzo		For	For
	15	Anthony R. Tersigni		For	For
	16	Janie Wade		For	For
2.	To approve our Fourth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance under our Third Amended and Restated 2010 Stock Incentive Plan by 4 million shares.		Management	For	For
3.	To approve, on an advisory basis, the frequency of advisory stockholder votes on the compensation of our Named Executive Officers.		Management	1 Year	Against
4.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.		Management	For	For

RALLYBIO CORPORATION

Security	75120L100	Meeting Type	Annual
Ticker Symbol	RLYB	Meeting Date	17-May-2023
Record Date	20-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Class II Director: Helen M. Boudreau	Management	For	For
1.2	Election of Class II Director: Lucian Iancovici	Management	For	For
1.3	Election of Class II Director: Christine A. Nash	Management	For	For
2.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.	Management	For	For

REGENERON PHARMACEUTICALS, INC.

Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	09-Jun-2023
Record Date	11-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Joseph L. Goldstein, M.D.	Management	For	For
1b.	Election of Director: Christine A. Poon	Management	For	For
1c.	Election of Director: Craig B. Thompson, M.D.	Management	For	For
1d.	Election of Director: Huda Y. Zoghbi, M.D.	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	Proposal to approve, on an advisory basis, executive compensation.	Management	For	For
4.	Proposal to approve, on an advisory basis, the frequency of future advisory votes on executive compensation.	Management	1 Year	For
5.	Non-binding shareholder proposal, if properly presented, requesting report on a process by which access to medicine is considered in matters related to protecting intellectual property.	Shareholder	Against	For

RESMED INC.

Security	761152107	Meeting Type	Annual
Ticker Symbol	RMD	Meeting Date	16-Nov-2022
Record Date	20-Sep-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to serve until our 2023 annual meeting: Carol Burt	Management	For	For
1b.	Election of Director to serve until our 2023 annual meeting: Jan De Witte	Management	For	For
1c.	Election of Director to serve until our 2023 annual meeting: Karen Drexler	Management	For	For
1d.	Election of Director to serve until our 2023 annual meeting: Michael Farrell	Management	For	For
1e.	Election of Director to serve until our 2023 annual meeting: Peter Farrell	Management	For	For
1f.	Election of Director to serve until our 2023 annual meeting: Harjit Gill	Management	For	For
1g.	Election of Director to serve until our 2023 annual meeting: John Hernandez	Management	For	For
1h.	Election of Director to serve until our 2023 annual meeting: Richard Sulpizio	Management	For	For
1i.	Election of Director to serve until our 2023 annual meeting: Desney Tan	Management	For	For
1j.	Election of Director to serve until our 2023 annual meeting: Ronald Taylor	Management	For	For
2.	Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2023.	Management	For	For
3.	Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").	Management	For	For

SABRA HEALTH CARE REIT, INC.

Security	78573L106	Meeting Type	Annual
Ticker Symbol	SBRA	Meeting Date	14-Jun-2023
Record Date	18-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Craig A. Barbarosh	Management	For	For
1b.	Election of Director: Katie Cusack	Management	For	For
1c.	Election of Director: Michael J. Foster	Management	For	For
1d.	Election of Director: Lynne S. Katzmann	Management	For	For
1e.	Election of Director: Ann Kono	Management	For	For
1f.	Election of Director: Jeffrey A. Malehorn	Management	For	For
1g.	Election of Director: Richard K. Matros	Management	For	For
1h.	Election of Director: Clifton J. Porter II	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of Sabra's named executive officers.	Management	For	For
4.	Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation.	Management	1 Year	For

SAREPTA THERAPEUTICS, INC.

Security	803607100	Meeting Type	Annual
Ticker Symbol	SRPT	Meeting Date	08-Jun-2023
Record Date	14-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Class II Director to hold office until the 2025 Annual Meeting: Richard J. Barry	Management	For	For
1.2	Election of Class II Director to hold office until the 2025 Annual Meeting: M. Kathleen Behrens, Ph.D.	Management	For	For
1.3	Election of Class II Director to hold office until the 2025 Annual Meeting: Stephen L. Mayo, Ph. D.	Management	For	For
1.4	Election of Class II Director to hold office until the 2025 Annual Meeting: Claude Nicaise, M.D.	Management	For	For
2.	Advisory vote to approve, on a non-binding basis, named executive officer compensation	Management	For	For
3.	Approve an amendment to the Company's 2018 Equity Incentive Plan (the "2018 Plan") to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 13,187,596 shares	Management	For	For
4.	Approve an amendment to the Amended and Restated 2013 Employee Stock Purchase Plan (as amended and restated on June 27, 2016 and amended on June 6, 2019) (the "2016 ESPP") to increase the number of shares of our common stock authorized for issuance under the 2016 ESPP by 300,000 shares to 1,400,000 shares	Management	For	For
5.	Advisory vote on whether an advisory vote on executive compensation should be held every one, two or three years	Management	1 Year	For
6.	Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2023	Management	For	For

STERIS PLC

Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	28-Jul-2022
Record Date	01-Jun-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Re-election of Director: Richard C. Breeden	Management	For	For
1b.	Re-election of Director: Daniel A. Carestio	Management	For	For
1c.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1d.	Re-election of Director: Christopher S. Holland	Management	For	For
1e.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1f.	Re-election of Director: Paul E. Martin	Management	For	For
1g.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1h.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1i.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2023.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting.	Management	For	For
4.	To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 14, 2022.	Management	For	For

STRYKER CORPORATION

Security	863667101	Meeting Type	Annual
Ticker Symbol	SYK	Meeting Date	10-May-2023
Record Date	13-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Mary K. Brainerd	Management	For	For
1b.	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1c.	Election of Director: Srikant M. Datar, Ph.D.	Management	For	For
1d.	Election of Director: Allan C. Golston	Management	For	For
1e.	Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President)	Management	For	For
1f.	Election of Director: Sherilyn S. McCoy (Lead Independent Director)	Management	For	For
1g.	Election of Director: Andrew K. Silvernail	Management	For	For
1h.	Election of Director: Lisa M. Skeete Tatum	Management	For	For
1i.	Election of Director: Ronda E. Stryker	Management	For	For
1j.	Election of Director: Rajeev Suri	Management	For	For
2.	Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2023.	Management	For	For
3.	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
4.	Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation.	Management	1 Year	For
5.	Shareholder Proposal on Political Disclosure.	Shareholder	Against	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	15-Jun-2023
Record Date	10-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: M. Braverman-Blumenstyk	Management	For	For
1C.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders.	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	15-Jun-2023
Record Date	08-May-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: M. Braverman-Blumenstyk	Management	For	For
1C.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders.	Management	For	For

THE CIGNA GROUP

Security	125523100	Meeting Type	Annual
Ticker Symbol	CI	Meeting Date	26-Apr-2023
Record Date	07-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: David M. Cordani	Management	For	For
1b.	Election of Director: William J. DeLaney	Management	For	For
1c.	Election of Director: Eric J. Foss	Management	For	For
1d.	Election of Director: Retired Maj. Gen. Elder Granger, M.D.	Management	For	For
1e.	Election of Director: Neesha Hathi	Management	For	For
1f.	Election of Director: George Kurian	Management	For	For
1g.	Election of Director: Kathleen M. Mazzarella	Management	For	For
1h.	Election of Director: Mark B. McClellan, M.D., Ph.D.	Management	For	For
1i.	Election of Director: Kimberly A. Ross	Management	For	For
1j.	Election of Director: Eric C. Wiseman	Management	For	For
1k.	Election of Director: Donna F. Zarcone	Management	For	For
2.	Advisory approval of The Cigna Group's executive compensation	Management	For	For
3.	Advisory approval of the frequency of future advisory votes on executive compensation	Management	1 Year	For
4.	Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023	Management	For	For
5.	Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law	Management	For	For
6.	Shareholder proposal - Special shareholder meeting improvement	Shareholder	Against	For
7.	Shareholder proposal - Political contributions report	Shareholder	Against	For

THERMO FISHER SCIENTIFIC INC.

Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	24-May-2023
Record Date	27-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Marc N. Casper	Management	For	For
1b.	Election of Director: Nelson J. Chai	Management	For	For
1c.	Election of Director: Ruby R. Chandy	Management	For	For
1d.	Election of Director: C. Martin Harris	Management	For	For
1e.	Election of Director: Tyler Jacks	Management	For	For
1f.	Election of Director: R. Alexandra Keith	Management	For	For
1g.	Election of Director: James C. Mullen	Management	For	For
1h.	Election of Director: Lars R. Sørensen	Management	For	For
1i.	Election of Director: Debora L. Spar	Management	For	For
1j.	Election of Director: Scott M. Sperling	Management	For	For
1k.	Election of Director: Dion J. Weisler	Management	For	For
2.	An advisory vote to approve named executive officer compensation.	Management	For	For
3.	An advisory vote on the frequency of future named executive officer advisory votes.	Management	1 Year	For
4.	Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2023.	Management	For	For
5.	Approval of the Company's Amended and Restated 2013 Stock Incentive Plan.	Management	For	For
6.	Approval of the Company's 2023 Global Employee Stock Purchase Plan.	Management	For	For

UNITED THERAPEUTICS CORPORATION

Security	91307C102	Meeting Type	Annual
Ticker Symbol	UTHR	Meeting Date	26-Jun-2023
Record Date	27-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Christopher Causey	Management	For	For
1b.	Election of Director: Raymond Dwek	Management	For	For
1c.	Election of Director: Richard Giltner	Management	For	For
1d.	Election of Director: Katherine Klein	Management	For	For
1e.	Election of Director: Ray Kurzweil	Management	For	For
1f.	Election of Director: Linda Maxwell	Management	For	For
1g.	Election of Director: Nilda Mesa	Management	For	For
1h.	Election of Director: Judy Olian	Management	For	For
1i.	Election of Director: Christopher Patusky	Management	For	For
1j.	Election of Director: Martine Rothblatt	Management	For	For
1k.	Election of Director: Louis Sullivan	Management	For	For
1l.	Election of Director: Tommy Thompson	Management	For	For
2.	Advisory resolution to approve executive compensation.	Management	For	For
3.	Advisory vote on the frequency of future advisory votes on executive compensation.	Management	1 Year	For
4.	Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan.	Management	For	For
5.	Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023.	Management	For	For

UNITEDHEALTH GROUP INCORPORATED

Security	91324P102	Meeting Type	Annual
Ticker Symbol	UNH	Meeting Date	05-Jun-2023
Record Date	10-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Timothy Flynn	Management	For	For
1b.	Election of Director: Paul Garcia	Management	For	For
1c.	Election of Director: Kristen Gil	Management	For	For
1d.	Election of Director: Stephen Hemsley	Management	For	For
1e.	Election of Director: Michele Hooper	Management	For	For
1f.	Election of Director: F. William McNabb III	Management	For	For
1g.	Election of Director: Valerie Montgomery Rice, M.D.	Management	For	For
1h.	Election of Director: John Noseworthy, M.D.	Management	For	For
1i.	Election of Director: Andrew Witty	Management	For	For
2.	Advisory approval of the Company's executive compensation.	Management	For	For
3.	Advisory approval of the frequency of holding future say-on-pay votes.	Management	1 Year	For
4.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023.	Management	For	For
5.	If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking a third-party racial equity audit.	Shareholder	Against	For
6.	If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report.	Shareholder	Against	For
7.	If properly presented at the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay.	Shareholder	Against	For

UNIVERSAL HEALTH REALTY INCOME TRUST

Security	91359E105	Meeting Type	Annual
Ticker Symbol	UHT	Meeting Date	07-Jun-2023
Record Date	10-Apr-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Trustee: Alan B. Miller	Management	For	For
1.2	Election of Trustee: Robert F. McCadden	Management	For	For
2.	Advisory (nonbinding) vote to approve named executive officer compensation.	Management	For	For
3.	Advisory (nonbinding) vote on the frequency of future advisory shareholder votes to approve named executive officer compensation.	Management	1 Year	For
4.	Proposal to ratify the selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.	Management	For	For

VERTEX PHARMACEUTICALS INCORPORATED

Security	92532F100	Meeting Type	Annual
Ticker Symbol	VRTX	Meeting Date	17-May-2023
Record Date	23-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Sangeeta Bhatia	Management	For	For
1.2	Election of Director: Lloyd Carney	Management	For	For
1.3	Election of Director: Alan Garber	Management	For	For
1.4	Election of Director: Terrence Kearney	Management	For	For
1.5	Election of Director: Reshma Kewalramani	Management	For	For
1.6	Election of Director: Jeffrey Leiden	Management	For	For
1.7	Election of Director: Diana McKenzie	Management	For	For
1.8	Election of Director: Bruce Sachs	Management	For	For
1.9	Election of Director: Suketu Upadhyay	Management	For	For
2.	Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2023.	Management	For	For
3.	Advisory vote to approve named executive office compensation.	Management	For	For
4.	Advisory vote on the frequency of future advisory votes on executive compensation.	Management	1 Year	For

WEST PHARMACEUTICAL SERVICES, INC.

Security	955306105	Meeting Type	Annual
Ticker Symbol	WST	Meeting Date	25-Apr-2023
Record Date	03-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Mark A. Buthman	Management	For	For
1b.	Election of Director: William F. Feehery	Management	For	For
1c.	Election of Director: Robert F. Friel	Management	For	For
1d.	Election of Director: Eric M. Green	Management	For	For
1e.	Election of Director: Thomas W. Hofmann	Management	For	For
1f.	Election of Director: Molly E. Joseph	Management	For	For
1g.	Election of Director: Deborah L. V. Keller	Management	For	For
1h.	Election of Director: Myla P. Lai-Goldman	Management	For	For
1i.	Election of Director: Stephen H. Lockhart	Management	For	For
1j.	Election of Director: Douglas A. Michels	Management	For	For
1k.	Election of Director: Paolo Pucci	Management	For	For
2.	Advisory vote to approve named executive officer compensation.	Management	For	For
3.	To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023.	Management	For	For
4.	Advisory vote on the frequency of an advisory vote on executive compensation.	Management	1 Year	For
5.	Shareholder proposal regarding Fair Elections.	Shareholder	For	Against

ZIMMER BIOMET HOLDINGS, INC.

Security	98956P102	Meeting Type	Annual
Ticker Symbol	ZBH	Meeting Date	12-May-2023
Record Date	13-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Christopher B. Begley	Management	For	For
1b.	Election of Director: Betsy J. Bernard	Management	For	For
1c.	Election of Director: Michael J. Farrell	Management	For	For
1d.	Election of Director: Robert A. Hagemann	Management	For	For
1e.	Election of Director: Bryan C. Hanson	Management	For	For
1f.	Election of Director: Arthur J. Higgins	Management	For	For
1g.	Election of Director: Maria Teresa Hilado	Management	For	For
1h.	Election of Director: Syed Jafry	Management	For	For
1i.	Election of Director: Sreelakshmi Kolli	Management	For	For
1j.	Election of Director: Michael W. Michelson	Management	For	For
2.	Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023	Management	For	For
3.	Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay")	Management	For	For
4.	Approve, on a non-binding advisory basis, the frequency of future Say on Pay votes	Management	1 Year	For

ZOETIS INC.

Security	98978V103	Meeting Type	Annual
Ticker Symbol	ZTS	Meeting Date	18-May-2023
Record Date	24-Mar-2023

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Paul M. Bisaro	Management	For	For
1b.	Election of Director: Vanessa Broadhurst	Management	For	For
1c.	Election of Director: Frank A. D'Amelio	Management	For	For
1d.	Election of Director: Michael B. McCallister	Management	For	For
1e.	Election of Director: Gregory Norden	Management	For	For
1f.	Election of Director: Louise M. Parent	Management	For	For
1g.	Election of Director: Kristin C. Peck	Management	For	For
1h.	Election of Director: Robert W. Scully	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2023.	Management	For	For
4.	Approval of an amendment to our Restated Certificate of Incorporation to create a right to call a special meeting.	Management	For	For
5.	Shareholder proposal regarding ability to call a special meeting.	Shareholder	Against	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)		Tekla Healthcare Opportunites Fund
By (Signature and Title)*
			/s/ Daniel R. Omstead
			(Daniel R. Omstead, President)
Date	8/4/23

*Print the name and title of each signing officer under his or her signature.

2